Mark A. Applebaum

45 papers receiving 1.8k citations

Mark A. Applebaum's Hit Papers

Advances in Risk Classification and Treatment Strategies for Neuroblastoma 2015 · 705 citations
7050+3+7Years since publication200400600

Peers

Mark A. Applebaum
Comparison fields: 5 of 85
  • Neurology 905
  • Speech and Hearing 58
  • Pulmonary and Respiratory Medicine 336
  • Cancer Research 136
  • Family Practice 10
Replace Beate Haeberle with:
Beate Haeberle Germany
Shaowen Xiao China
Patricia O. Whitcomb United States
Cormac Owens Ireland
Araz Marachelian United States
Giulio Cantù Italy
Xiaoxi Lin China
Carolina Cavaliéri Gomes Brazil
Dan S. Gombos United States
Yasumasa Monobe Japan
Mark A. Applebaum relative to Beate Haeberle Germany Beate Haeberle's profile →
Citations per field
00.5×2×4×5.0×
Beate Haeberle · 1×
Citations per year

Countries citing papers authored by Mark A. Applebaum

Since Specialization
Citations

This map shows the geographic impact of Mark A. Applebaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Applebaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Applebaum more than expected).

Fields of papers citing papers by Mark A. Applebaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Applebaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Applebaum. The network helps show where Mark A. Applebaum may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Applebaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Applebaum Line = papers co-authored together Mark A. Applebaum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Hit paper breakdown →
2015705
2 2011204
3 201662
4 202061
5 201860
6 201157
7 201455
8 201150
9 202249
10 201947
11 201345
12 201734
13 202433
14 201632
15 201926
16 201924
17 202023
18 201722
19 202322
20 202321

About Mark A. Applebaum

Mark A. Applebaum is a scholar working on Neurology, Pulmonary and Respiratory Medicine, Cancer Research, Speech and Hearing and Epidemiology, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (27 papers), Sarcoma Diagnosis and Treatment (6 papers), Multiple and Secondary Primary Cancers (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer Genomics and Diagnostics (3 papers), Ultrasound and Hyperthermia Applications (2 papers), Adolescent and Pediatric Healthcare (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Neurology (905 citations), Speech and Hearing (58 citations), Pulmonary and Respiratory Medicine (336 citations), Cancer Research (136 citations) and Family Practice (10 citations). Mark A. Applebaum has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Susan Lerner Cohn, Katherine K. Matthay, Samuel L. Volchenboum, Navin R. Pinto, Julie R. Park, Wendy B. London, Andrew D.J. Pearson, Gudrun Schleiermacher, Dominique Valteau‐Couanet and Frank Berthold. Their work appears in journals such as Pediatric Blood & Cancer, JCO Precision Oncology, Cancer, Oncotarget and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact